PharmaSource: The External Manufacturing Community Essential intelligence for biopharma outsourcing leaders | Trusted by 50,000+ professionals | Subscribe TOP STORIES WuXi Biologics’ Hebei Facility Passes FDA Pre-License Inspection for Autoimmune Therapy Read More » Olon Doubles Production Capacity at Concord Manufacturing Facility NetraMark Signs First CRO-Channelled Contract to Apply NetraAI Platform to Phase 2 Neurodegeneration Trial Data ProPharma Deploys Proprietary AI Capability to Accelerate ANDA Submission Development for Regulatory CRO Clients RoslinCT Partners with BlueRock Therapeutics to Expand Access to Clinical-Grade Stem Cell Lines Fujifilm Biotechnologies Selected for FDA PreCheck Pilot Program at Holly Springs Facility Evonik Invests US$100 Million to Expand Indiana API CDMO Manufacturing A Category 5 Super Typhoon Is Tracking Toward 630 China and Taiwan Pharma Manufacturing Sites Catalent Expands Partnership With Nanoscope Therapeutics to Support MCO-010 Commercial Supply Mikart Appoints Darrin Schellin as Chief Executive Officer CDMO World Cup: Comparing Global Contract Manufacturing Powerhouses CNR Research Posts Record CRO Order Backlog as Overseas Contracts and AI Platform Transition Drive Growth Matica Biotechnology Partners with VaxDome to Advance Hybrid Antiviral Vaccine Candidates Codis Acquires Catalent’s UK Facility to Expand Oral Solid Dose CDMO Services Besins Healthcare Acquires UniD Manufacturing to Expand Long-Acting Drug Delivery Capabilities Lonza Acquires Nona Biosciences’ Blood-Brain Barrier Technology for CNS Therapies More news + insights Olon Doubles Production Capacity at Concord Manufacturing Facility NetraMark Signs First CRO-Channelled Contract to Apply NetraAI Platform to Phase 2 Neurodegeneration Trial Data ProPharma Deploys Proprietary AI Capability to Accelerate ANDA Submission Development for Regulatory CRO Clients PODCASTS The Rezon Bio Story: Interview with Dr. Adriana Kiedzierska-Mencfeld 6 CMC Strategies Are Transforming Biologics Drug Development SPOTLIGHT Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success RESOURCES Resilience, Risk & Relationships – ExM Leaders Report [DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success UPCOMING EVENTS External Manufacturing Leaders Basel 2026 CDMO Live Americas . October 20-21, Boston 2026 CDMO Live Europe 2027
NetraMark Signs First CRO-Channelled Contract to Apply NetraAI Platform to Phase 2 Neurodegeneration Trial Data
ProPharma Deploys Proprietary AI Capability to Accelerate ANDA Submission Development for Regulatory CRO Clients
CNR Research Posts Record CRO Order Backlog as Overseas Contracts and AI Platform Transition Drive Growth
NetraMark Signs First CRO-Channelled Contract to Apply NetraAI Platform to Phase 2 Neurodegeneration Trial Data
ProPharma Deploys Proprietary AI Capability to Accelerate ANDA Submission Development for Regulatory CRO Clients